News | Congenital Heart | October 24, 2019

University of Arizona Leads Statewide Study of Congenital Heart Defects

The University of Arizona Division of Pediatric Cardiology Congenital Heart Program will explore the public health problem of congenital heart defects among children, adolescents and adults through a five-year project

University of Arizona Leads Statewide Study of Congenital Heart Defects

October 24, 2019 — Investigators at the University of Arizona Steele Children's Research Center are leading a statewide study as part of a national effort to conduct population-based surveillance of congenital heart defects across the life span, thanks to funding from the U.S. Centers for Disease Control and Prevention (CDC).

Jennifer Andrews, Ph.D., an assistant professor in the Department of Pediatrics and a member of the UA Steele Children's Research Center, has received $2.4 million through a five-year CDC cooperative agreement. Under the agreement, she will examine survival, healthcare utilization, other health conditions and outcomes over time for a variety of geographically, culturally and socioeconomically challenged subpopulations of Arizona children, adolescents and adults living with congenital heart defects.

In 2012, the CDC started expanding enhanced public health tracking of congenital heart defects to include children, adolescents and adults. This project seeks to better understand the survival, healthcare use and longer-term outcomes of individuals born with congenital heart defects across their life span. Understanding these health issues and needs at all ages is vital to improve the lives of individuals living with congenital heart disease, Andrews said.   

An estimated 40,000 children are born with a heart problem each year, 25 percent of whom will have a critical heart condition requiring surgery during the first year of life. Treatment advances have changed the natural history of congenital heart disease; today, most infants born with a critical congenital heart condition are expected to live into adolescence and adulthood, but little is known about their outcomes.

"This project will establish a much-needed understanding of the scope of congenital heart defects, a complex set of conditions that afflict more than 2.4 million people in the United States," said UA President Robert C. Robbins, M.D. "Thanks to progress from collaborative pediatric cardiology and cardiothoracic surgery teams, such as the one at the UA College of Medicine – Tucson, young people born with complex heart conditions are more likely than ever to grow up to be adults with fulfilling lives. Yet more than half of all those who are afflicted with congenital heart disease are adults, and by monitoring and treating throughout the life span, we will better understand how to help individuals of all ages."

This cooperative agreement will expand the research program within the Division of Pediatric and Congenital Cardiology, led by Scott Klewer, M.D., professor of pediatrics, medicine and cellular and molecular medicine at the College of Medicine – Tucson. Andrews is director of research for the Congenital Heart Program. She and Klewer also are members of the UA Sarver Heart Center. Klewer holds the UA Sarver Heart Center Peggy M. Barrett Endowed Chair for Congenital Heart Disease in Adults.

For more information: www.peds.arizona.edu/steele

Related Content

News | Cardiovascular Clinical Studies

August 12, 2022 — Older adults with atrial cardiopathy (a major, often undetected cardiac cause of stroke) may be at ...

Home August 12, 2022
Home
News | Cardiovascular Clinical Studies

August 8, 2022 — Two years ago, University of Alabama at Birmingham researchers and colleagues reported that reductive ...

Home August 08, 2022
Home
News | Cardiovascular Clinical Studies

July 22, 2022 — BioSig Technologies, Inc. a medical technology company advancing electrophysiology workflow by ...

Home July 22, 2022
Home
News | Cardiovascular Clinical Studies

July 18, 2022 — scPharmaceuticals Inc., a pharmaceutical company focused on developing and commercializing products that ...

Home July 19, 2022
Home
News | Cardiovascular Clinical Studies

July 15, 2022 — Imagine, if scientists had a map of the heart, so granular in its accuracy that it even profiled details ...

Home July 15, 2022
Home
News | Cardiovascular Clinical Studies

July 11, 2022 — Smoking traditional or non-combustible cigarettes while wearing a surgical mask results in a two-fold ...

Home July 12, 2022
Home
News | Cardiovascular Clinical Studies

June 24, 2022 — Henry Ford Health was part of a multi-institutional heart failure study that was launched and executed ...

Home June 24, 2022
Home
News | Cardiovascular Clinical Studies

June 21, 2022 — Renibus Therapeutics (“Renibus”), a clinical-stage biotech company focusing on the prevention and ...

Home June 21, 2022
Home
News | Cardiovascular Clinical Studies

June 13, 2022 — Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that ...

Home June 13, 2022
Home
News | Cardiovascular Clinical Studies

June 1, 2022 — Biofourmis, a Boston-based global leader in virtual care and digital medicine, announced that its ...

Home June 01, 2022
Home
Subscribe Now